Abattis Bioceuticals Corp. Stock Analysis ATTBF
United States Health Care Nano Cap Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-04-09. The firm aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. The company operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. The company offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. The company is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Read More Abattis Bioceuticals Corp (ATTBF) Chart
Financial Metrics & Statements of Abattis Bioceuticals Corp (ATTBF)
FAQ's for Abattis Bioceuticals Corp (ATTBF)
- According to Musaffa’s Shariah screening methodology, Abattis Bioceuticals Corp (ATTBF) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Alternate Halal Stocks for Abattis Bioceuticals Corp (ATTBF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
